Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Hospira Recalls Three Lots of Propofol Injectable Emulsion: Now, AttorneyOne Can Provide Advice for Legal Counsel in Case of Side Effects

March 27, 2013

On February 25th, 2013, Hospira announced the recall of three lots of Propofol Injectable Emulsion due to visible particles embedded in the glass. In light of these news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Propofol side effects. http://www.attorneyone.com/propofol-recall/

San Diego, CA (PRWEB) March 27, 2013

AttorneyOne.com, a recognized authority on law, updated the website recently and is now actively providing expert opinion in view of the recent news on Propofol and Propofol Lawsuit.

On February 25th, 2013, Hospira announced the recall of three lots of Propofol Injectable Emulsion due to visible particles embedded in the glass. Propofol (marketed as Diprivan and as generic products) is a sedative hypnotic agent labeled for induction, and maintenance of anesthesia and for continuous sedation in mechanically ventilated patients. According to the announcement, risks associated with this defect may include tissue necrosis in one or more organs that could result in stroke, myocardial infarction, respiratory failure, and loss of renal and hepatic function.

As Bloomberg reported on February 28th, 2012, Teva shelled more than $250 million to settle more than 80 lawsuits alleging the company sold the anesthetic Propofol in a way that led colonoscopy patients to develop hepatitis C.

Taking into consideration the latest developments, AttorneyOne.com updated the website and, now, can actively provide an expert opinion including how to get in contact with legal counsel easily and inexpensively in case of alleged Propofol severe complications. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that the alleged threat from Propofol remains. For that reason,” he continues, “our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

In May 2010, Teva announced discontinuation of Propofol after FDA´s warning that an inspection showed problems with the manufacture of the drug and a court order to pay $356 million to a plaintiff in damages claiming that he contracted hepatitis C as a direct result of product misuse related to unsafe clinical practices from reuse of vials of the drug (Case no. 08A571172, District Court, Clark County, Nevada).

AttorneyOne.com has further information on Propofol lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2013/3/prweb10565809.htm

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/3/prweb10573066.htm


Source: prweb